tyrosine kinase inhibitor
midostaurin
venetoclax
thioguanine
ponatinib
olutasidenib
roscovitine
ivosidenib
idelalisib
antileukemic
chloraminophene
omacetaxine
antileukemia
ruxolitinib
asciminib
myeloleukemia
vosaroxin
carfilzomib
talacotuzumab
lenalidomide
pacritinib
pomalidomide
melphalan flufenamide
leukemic
homoharringtonine
isatuximab
clofarabine
tafasitamab
pegaspargase
506U78
promyeloleukemia
ubenimex
myeloleukemic
preleukemia
atiprimod
cytarabine
chemodrug
chemo
Alkeran
chronic leukemia
leukemogenicity
melphalan
antileprotic
picoplatin
trilaciclib
cytotoxic drug
acute lymphoblastic leukemia
belantamab mafodotin
chemicotherapeutic
folinic acid